J&J sues federal government for halting 340B rebate plan
The New Jersey-based drugmaker is trying to get the courts’ backing to pay hospitals rebates for two drugs in the 340B drug discount program, instead of offering upfront discounts.
The New Jersey-based drugmaker is trying to get the courts’ backing to pay hospitals rebates for two drugs in the 340B drug discount program, instead of offering upfront discounts.
Saum Sutaria doesn’t think the ACA marketplace is going anywhere under President-elect Donald Trump, noting beneficiaries are an “important part of the electorate” for the incoming administration.
Medical groups’ median investment per employed physician reached $304,312 in the third quarter, the first time the metric has risen above $300,000, according to Kaufman Hall.
The plan requires only copays for medical services and prescription drugs up to the plan member’s out-of-pocket maximum, with no deductibles or coinsurance costs.
The DOJ’s complaint is intentionally broad to maximize its chances of success, according to one expert. Still, the incoming Trump administration could throw cold water on the challenge.
Don’t settle for burdensome EHRs built in the 90s. A new intuitive, AI-enabled EHR is on the way.
In a sample of 100 hospitals, 34 didn’t meet requirements for publishing machine-readable files of their charges while 14 didn’t follow rules to post shoppable services.
Kaiser said it would institute cost-cutting measures in response to the lackluster financial results, but didn’t detail specifics.
However, CEO Joe Almeida stressed that the earliest that new products could start to ship from the plant is late November.
Community Health Systems aims to net $1 billion or more in total proceeds from hospital sales.